Similar findings were reported by Laxman et al., who by incorporating four urine biomarkers, including PCA3 and TMPRSS2:ERG, achieved a 65.9% specificity and 76.0% sensitivity in PCa detection. The gene discussed is PCA3; the disease is posterior cortical atrophy.